Finnish ag-ingredients-branded foods player Raisio has turned in its best ever quarter and said a focus on emerging markets is driving ongoing sales growth in the sluggish plant stanol, cholesterol reduction category.
As Nestlé put a brave face on underwhelming first half results that fell far below market expectations, its Jenny Craig weight management brand was singled out as being one of its worst performing.
Food firm Kerry Group has posted promising half yearly figures despite UK brands flat-lining in spreads and frozen food as a result of heavy promotions and the horsemeat effect.
Nestlé has cut its sales growth expectations for the full year – but even the revised target will be a stretch, according to the company’s financial chief.
Organic growth and a healthy boost from last year’s €500m Fortitech investment lifted Q2 pre-tax profits 19% to €345m at Dutch ingredients and chemicals giant, Royal DSM.
€13bn Belgian supplier Solvay has sold its Solactis nutrition division that includes galactofructose (lactulose) to its former nutrition programme manager.
Tate & Lyle CEO Javed Ahmed says earning and profit forecasts are intact – “mid single digit growth” – despite an unseasonably cold spring that has contributed to an annual drop of 4% in the US soft drinks market and hit its specialty and bulk sweeteners...
The Alimentary Pharmabiotic Centre (APC) in Cork, Ireland has received a €36m investment from the Irish government that will fund its research activities for at least another six years, its GM told us this morning.
UK firm Provexis has filed to demerge the Science in Sport (SiS) consumer sports brand it purchased for €10m in June 2011 from its Fruitflow tomato-based ingredients business, as it believes the separation will increase the market value and perception...
Swiss nutra and pharma ingredient player Bioseutica has sold 85% of its KD Pharma high-end omega-3 business to German equity firm Capiton. Serious expansion is planned.
Naturex hosted 500 of its employees and guests the weekend just passed as it inaugurated a €12m expansion of its Avignon HQ in southern France. We caught up with CEO Thierry Lambert who said further expansion at its other global sites was very much on...
Naturex has seen sales rise 13.2% to €83.2m in Q1 2013, with Nutrition its star core business performer, leaping about 33% from €22m to just over €29m.
GlaxoSmithKline will sell its “iconic brands” Lucozade and Ribena to a beverage giant – if the price is right – the company announced in its Q1 results yesterday.
The European soy sector says a UN report that found dairy proteins offer a superior amino acid profile to plant proteins is only meaningful for the malnourished.
Costs relating to the establishment of the a2 Milk UK joint venture contributed to a H1 profits decrease for Australasian dairy processor A2 Corporation (A2C), the company has revealed.
Finnish ag-food giant Raisio has sold its €7m a year oat, soy and rice foods business that includes its Soygurt business to €330m Norwegian food company Kavli.
Food supplement markets in Poland, the Czech Republic, Romania, Hungary, Bulgaria and Slovakia have pushed through the €1bn mark for the first time, with Romania starring with 24% growth in 2011, says a new report.
Nestlé has bought its second brain health-focused medical foods start-up in eight months after snaffling Red River Pharma-owned Pamlab which makes high-dose vitamin supplements targeting depression, diabetes and Alzheimer’s.
Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.
Southern Israel-based algae-sourced astanxanthin specialists Algatechnologies has won investment from a UK venture capitalist in a move that will broaden its capacity, R&D and distribution scope for the eye and skin health carotenoid.
Nutrition Capital Network noted a record 247 deals in the health and wellness sector in 2012. Within that number, the group noted a decline in the number of M&A deals from the previous year, but an increase in financings.
Two leading European ingredients suppliers have bucked hard economic times to post strong results for 2012, with French botanical extracts specialist, Naturex, and Finish agriculture, ingredients and brand owner, Raisio, talking up aggressive acquisition...
The European probiotic sector is bracing itself for tough times ahead in the wake of December’s EU health claim ban for the sector, but the effects are yet to be felt at Swedish supplier Probi which notched 6% sales growth in 2012.
At just seven years old, Chobani is a poster boy in the eyes of some, a market-devouring monster in the eyes of others. The New York-based Greek yogurt giant’s expansion plans in North America, Europe and Australasia are ambitious. But is it taking on...
BASF says revised offer for omega-3 API maker Pronova Biopharma is fair value given recent Greek Government decision to stop reimbursing two key drugs.
The economic crisis has hit the EU hard, and coupled with a severe health and nutrition claim clamp down, the past years have been challenging for the European nutra industry.
A day after confirming the €500m acquisition of New York-based blends specialist Fortitech, Royal DSM has concluded the year by buying beta-glucan brand Oatwell from Swedish Oat Fiber (SOF).
BASF has extended the bid period for its €650m offer to buy high-dose omega-3 specialist Pronova BioPharma, after only 67.2% of the Norwegian firm’s shareholders agreed to sell their stakes.
BASF is moving en masse into omega-3 - especially if its bid for Norwegian player Pronova is approved - but it is technology gained from its May acquisition of a high-dose omega-3 start-up on a remote Scottish island, that is exciting the German giant.
Swiss biotech firm Evolva has bought failing Fluxome’s, yeast-derived resveratrol business for about €550,000 in cash and shares, but says it has no interest in the remaining omega-3 business being sold by sealed auction.
Nestlé has amplified its nutrition presence by forming a joint venture to develop Traditional Chinese Medicines (TCM). Orally consumed gastro products will be first off the rank based on an extract from the andrographis paniculata plant grown in Indian...
DKSH’s Performance Materials unit has paid undisclosed sum for Swiss ingredients and chemicals firm Staerkle & Nagler, as the Asian player moves to boost its European presence.
UK-based consumer goods firm Reckitt Benckiser told NutraIngredients today, “nutrition had been on its radar for awhile”, as it plunged $1.4bn (€1.09bn) to outbid German pharma firm Bayer for the US’s second biggest dietary supplements firm, Schiff Nutrition...
Swiss biotech firm Evolva has agreed to buy undisclosed assets from Fluxome, as it leaves its pure pharma research past in the dust and throws the embattled Danish supplier a lifeline.
Croatian food company Atlantic Grupa has won a €307m finance package from the European Bank for Reconstruction and Development (EBRD) for new energy systems, sustainability certifications and working capital financing.
Rampant nutrition business acquirer, Royal DSM, has splashed the cash for the ninth time in two years – this time to the tune of €495m ($634m) on US-based multinational nutrient blending giant, Fortitech (€212m/$270m annual turnover).
Ingredients, grain, snack brand and stanol-based cholesterol-lowering Benecol brand owner Raisio had a healthy Q3 with revenues up 14% to €160m from €141.7m in Q3 2011.
The consumer arm of German pharma giant Bayer Healthcare is to pay $1.2bn (€920m) for US food supplements company Schiff Nutrition International, a move that will make it one of the biggest operators there, feed product development globally, and may not...
BASF’s nutrition and health unit (N&H) earned €492m in Q3 – 4% more for the quarter than in 2011 when it had sales of €471m – despite falling prices for most vitamins.
Food and nutrition giant Nestlé has reported improved sales in its 9-month results driven by growth in emerging markets, but Q3 was a little slower than last year.
Frutarom has posted strong double digit growth figures for its second quarter/half year results, driven by acquisitions, organic growth, price increases, falling raw material costs and more favourable purchasing deals.
Europe and North America were the worst performing regions for Nestlé according to its first half (H1) results, while Asia, Oceania, Africa and emerging markets delivered double digit growth.
Royal DSM paid tribute to its nutrition division which held steady as its sales and profits dipped for the second quarter and first half of the financial year, as recessed global economies took their toll on bottom lines.
